PROJECT NAME


MatriSys Bioscience, Inc., a clinical stage Skin Microbiome Development company. Prof. Richard Gallo, UCSD Dermatology Chief, co-founder, SAB head, and a world leader in the use of microbes as novel medicines. NIH funded microbiome Phase I/II clinical program in Atopic Dermatitis (“AD”) market with 15 M US patients. 6 Partner discussions underway today, in diligence